Immunogenic cell death and DAMPs in cancer therapy
- PMID: 23151605
- DOI: 10.1038/nrc3380
Immunogenic cell death and DAMPs in cancer therapy
Abstract
Although it was thought that apoptotic cells, when rapidly phagocytosed, underwent a silent death that did not trigger an immune response, in recent years a new concept of immunogenic cell death (ICD) has emerged. The immunogenic characteristics of ICD are mainly mediated by damage-associated molecular patterns (DAMPs), which include surface-exposed calreticulin (CRT), secreted ATP and released high mobility group protein B1 (HMGB1). Most DAMPs can be recognized by pattern recognition receptors (PRRs). In this Review, we discuss the role of endoplasmic reticulum (ER) stress and reactive oxygen species (ROS) in regulating the immunogenicity of dying cancer cells and the effect of therapy-resistant cancer microevolution on ICD.
Similar articles
-
Many faces of DAMPs in cancer therapy.Cell Death Dis. 2013 May 16;4(5):e631. doi: 10.1038/cddis.2013.156. Cell Death Dis. 2013. PMID: 23681226 Free PMC article. Review.
-
An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.Angew Chem Int Ed Engl. 2021 Feb 23;60(9):4657-4665. doi: 10.1002/anie.202013987. Epub 2021 Jan 4. Angew Chem Int Ed Engl. 2021. PMID: 33217194
-
The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: From sensor to the plasma membrane and beyond.Semin Cancer Biol. 2015 Aug;33:74-85. doi: 10.1016/j.semcancer.2015.03.010. Epub 2015 Apr 13. Semin Cancer Biol. 2015. PMID: 25882379 Review.
-
Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies.Cancer Lett. 2018 Dec 1;438:17-23. doi: 10.1016/j.canlet.2018.08.028. Epub 2018 Sep 11. Cancer Lett. 2018. PMID: 30217563 Review.
-
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death.EMBO J. 2012 Mar 7;31(5):1062-79. doi: 10.1038/emboj.2011.497. Epub 2012 Jan 17. EMBO J. 2012. PMID: 22252128 Free PMC article.
Cited by
-
Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes.Front Immunol. 2021 May 7;12:642285. doi: 10.3389/fimmu.2021.642285. eCollection 2021. Front Immunol. 2021. PMID: 34025653 Free PMC article. Review.
-
Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements.Front Immunol. 2022 Aug 25;13:953410. doi: 10.3389/fimmu.2022.953410. eCollection 2022. Front Immunol. 2022. PMID: 36091031 Free PMC article. Review.
-
Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment.Front Immunol. 2022 Sep 23;13:998653. doi: 10.3389/fimmu.2022.998653. eCollection 2022. Front Immunol. 2022. PMID: 36211436 Free PMC article.
-
BQ-AurIPr: a redox-active anticancer Au(i) complex that induces immunogenic cell death.Chem Sci. 2022 Aug 25;13(36):10779-10785. doi: 10.1039/d2sc03756d. eCollection 2022 Sep 21. Chem Sci. 2022. PMID: 36320699 Free PMC article.
-
Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma.Oncotarget. 2015 Feb 10;6(4):2250-62. doi: 10.18632/oncotarget.2948. Oncotarget. 2015. PMID: 25544770 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials